ZBIOZenas BioPharma, Inc.
$27.24+44% 1Y
$27.24
$15.2052 weeks$43.17
Is the price fair?
What ZBIO's price assumes
- Price / book
- 6.30
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 6.30
- EV / EBIToperating margin −47557%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $1.56B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry